nelfinavir has been researched along with Hepatitis C, Chronic in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chichino, G; Donadel, E; Genco, F; Ladisa, N; Malicarne, L; Martini, S; Masala, A; Maserati, R; Meroni, V; Narciso, P; Occhino, C; Perini, P; Ravasi, G; Testa, L; Uglietti, A | 1 |
| Bernard, E; Del Giudice, P; Dellamonica, P; Marq, L; Perrin, C; Vandenbos, F | 1 |
| Arizcorreta-Yarza, A; Becker, MI; Caballero-Granado, FJ; Girón-González, JA; Gómez-Mateos, J; González-Serrano, M; Jiménez-Mejías, ME; Macías, J; Merino, D; Mira, JA; Pineda, JA; Terrón, A; Torre-Cisneros, J | 1 |
3 other study(ies) available for nelfinavir and Hepatitis C, Chronic
| Article | Year |
|---|---|
Nelfinavir+M8 plasma levels determined with an ELISA test in HIV infected patients with or without HCV and/or HBV coinfection: the VIRAKINETICS II study.
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Enzyme-Linked Immunosorbent Assay; Female; Hepatitis B, Chronic; Hepatitis C, Chronic; HIV Infections; Humans; Male; Middle Aged; Nelfinavir; Plasma | 2009 |
Sweet's syndrome following abacavir therapy.
Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Dideoxynucleosides; Female; Hepatitis C, Chronic; HIV Infections; Humans; Lamivudine; Middle Aged; Nelfinavir; Reverse Transcriptase Inhibitors; Sweet Syndrome; Trimethoprim, Sulfamethoxazole Drug Combination | 2004 |
Incidence of and risk factors for severe hepatotoxicity of nelfinavir-containing regimens among HIV-infected patients with chronic hepatitis C.
Topics: Adult; Anti-HIV Agents; Chemical and Drug Induced Liver Injury; Drug Administration Schedule; Drug Therapy, Combination; Female; Hepatitis C, Chronic; HIV Infections; Humans; Incidence; Male; Nelfinavir; Retrospective Studies; Risk Factors | 2006 |